Publication:
Use of antifungal agents for oral candidiasis: results of a national survey

Thumbnail Image
Files
Int J Dental Hygiene - 2010 - Martínez‐Beneyto - Use of antifungal agents for oral candidiasis results of a national.pdf(552.27 KB)
Date
2010-02-01
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Martínez Beneyto, Yolanda ; López-Jornet, Pia ; Velandrino-Nicolás, A. ; Jornet García, V.
item.page.secondaryauthor
item.page.director
Publisher
Wiley
publication.page.editor
publication.page.department
Dermatología, Estomatología, Radiología y Medicina Física
DOI
https://doi.org/10.1111/j.1601-5037.2008.00357.x
item.page.type
info:eu-repo/semantics/article
Description
© 2009 John Wiley & Sons A ⁄ S. This document is the Published version of a Published Work that appeared in final form in International Journal of Dental Hygiene. To access the final edited and published work see https://doi.org/10.1111/j.1601-5037.2008.00357.x
Abstract
Abstract: Background: Candida albicans is an opportunistic agent that colonizes the oral mucosa. Objectives: To determine the attitude of Spanish dentists toward the oral treatment of candidiasis. Method: Between May and November 2006, a questionnaire was circulated to a random selection of 1134 dentists obtained from the General Dental Council’s main list. The survey consisted of a block of socio-demographic items followed by another block related to the diagnosis and treatment of oral candidiasis. Replies to the questionnaire were received from 840 (74%) dentists. Results: 50.4% of respondents were men, and 48.1% were female with a mean age of 38 and 12.2 years of professional experience. Miconazole was the most popular choice of antifungal agent prescribed (59.3%), followed by nystatin (57.7%) for topical use. Systemic antifungal agents were used by 30.20% of dentists, with a strong association between their use and the number of years in practice, gender and professional qualifications (P < 0.005). Conclusion: Most Spanish dentists make clinical diagnosis and treat oral infections by C. albicans themselves with topical drugs (miconazole and nystatin) as a first choice. Systemic treatments are more commonly chosen by male dentists with long professional experience, especially by stomatologists.
publication.page.subject
Antifungal agent , Candida , Dentistry , Myconazole , Nystatine , Oral disease
Citation
Int J Dent Hygiene 8, 2010; 47–52
URI
http://hdl.handle.net/10201/147808
item.page.embargo
Collections
Artículos
Ir a Estadísticas